Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Hiroko Kishikawa, Ph.D.


This page shows the publications Hiroko Kishikawa has written about Ribonuclease, Pancreatic.
Connection Strength

  1. Targeting angiogenin in therapy of amyotropic lateral sclerosis. Expert Opin Ther Targets. 2008 Oct; 12(10):1229-42.
    View in: PubMed
    Score: 0.363
  2. Plexin-B2 Mediates Physiologic and Pathologic Functions of Angiogenin. Cell. 2017 Nov 02; 171(4):849-864.e25.
    View in: PubMed
    Score: 0.170
  3. Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis. Ann Neurol. 2011 Dec; 70(6):964-73.
    View in: PubMed
    Score: 0.113
  4. Angiogenin prevents serum withdrawal-induced apoptosis of P19 embryonal carcinoma cells. FEBS J. 2010 Sep; 277(17):3575-87.
    View in: PubMed
    Score: 0.103
  5. Angiogenin-stimulated rRNA transcription is essential for initiation and survival of AKT-induced prostate intraepithelial neoplasia. Mol Cancer Res. 2009 Mar; 7(3):415-24.
    View in: PubMed
    Score: 0.093
  6. Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis. Ann Neurol. 2007 Dec; 62(6):609-17.
    View in: PubMed
    Score: 0.086
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.